Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_assertion type Assertion NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_head.
- NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_assertion description "[Combination therapy with BRAF and MEK inhibitors is a recommended treatment strategy for metastatic melanoma patients with BRAF(V600) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_provenance.
- NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_assertion evidence source_evidence_literature NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_provenance.
- NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_assertion SIO_000772 26331795 NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_provenance.
- NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_assertion wasDerivedFrom befree-2016 NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_provenance.
- NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_assertion wasGeneratedBy ECO_0000203 NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_provenance.